Literature DB >> 35505006

Application of Monolayer Cell Cultures for Investigating Basic Mechanisms of Photodynamic Therapy.

Mans Broekgaarden1.   

Abstract

Conventional monolayer cell cultures continue to be an inexpensive and highly accessible model of human disease that can be easily harnessed to study the molecular and cellular mechanisms of photodynamic therapy (PDT). In this communication, a collection of informative assays for conventional cell cultures are provided to determine (1) the photosensitizer uptake kinetics and localization, (2) the efficacy of PDT using metabolism- or protein-based quantification methods, (3) the effects of PDT and combination treatments on the cell cycle, (4) the cell death pathways induced by PDT, and (5) the extent of mitochondrial membrane permeabilization of PDT and photochemotherapy combinations. For each type of assay, examples from the recent literature are provided in which novel photosensitizers, their nanocarriers, and various PDT-based combination therapies are investigated. Together, these assays are examples of approaches by which monolayer cell cultures can be used as a simple yet robust and versatile model to investigate PDT.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cytotoxicity; Dosimetry; Flow cytometry; Fluorescence microscopy; In vitro; Metabolism; Photochemotherapy; Phototherapy; Viability

Mesh:

Substances:

Year:  2022        PMID: 35505006     DOI: 10.1007/978-1-0716-2099-1_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  50 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 2.  Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.

Authors:  Aisling E O'Connor; William M Gallagher; Annette T Byrne
Journal:  Photochem Photobiol       Date:  2009-08-03       Impact factor: 3.421

Review 3.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 4.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.

Authors:  Girgis Obaid; Isabelle Chambrier; Michael J Cook; David A Russell
Journal:  Photochem Photobiol Sci       Date:  2015-04       Impact factor: 3.982

6.  Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy.

Authors:  M Broekgaarden; R van Vught; S Oliveira; R C Roovers; P M P van Bergen en Henegouwen; R J Pieters; T M Van Gulik; E Breukink; M Heger
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

7.  Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.

Authors:  Mans Broekgaarden; Ruud Weijer; Alebert C van Wijk; Ruud C Cox; Maarten R Egmond; Ron Hoebe; Thomas M van Gulik; Michal Heger
Journal:  J Biomed Nanotechnol       Date:  2017-02       Impact factor: 4.099

Review 8.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 9.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects.

Authors:  K Plaetzer; B Krammer; J Berlanda; F Berr; T Kiesslich
Journal:  Lasers Med Sci       Date:  2008-02-05       Impact factor: 3.161

10.  Targeting the oncofetal Thomsen-Friedenreich disaccharide using jacalin-PEG phthalocyanine gold nanoparticles for photodynamic cancer therapy.

Authors:  Girgis Obaid; Isabelle Chambrier; Michael J Cook; David A Russell
Journal:  Angew Chem Int Ed Engl       Date:  2012-05-09       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.